Company intelligence / Profile preview

BIO-CAT

Troy, Virginia, United Statesbio-cat.com ↗
Ownership
Private
Employees
~56
Development stage
Commercial
01

Overview

BIO-CAT develops and manufactures natural enzymes and microbial products—primarily Bacillus-based probiotics—for use in human dietary supplements, animal feed/nutrition, agriculture/crop science, water treatment, and related industries. The company operates FSSC22000-certified facilities with state-of-the-art fermentation capacity. It does not conduct clinical trials in the pharmaceutical sense but supports product innovation through R&D partnerships with supplement manufacturers. No traditional clinical results are published as the company supplies ingredients rather than finished therapeutics. Their exclusive relationships with top Japanese enzyme manufacturers further enhance their portfolio.

Therapeutic areas
GastroenterologyOther
Modalities
Enzyme (Biologic)Probiotic (Live biotherapeutic product therapy)Microbial therapy
Industry
Non-Drug Biotech
02

Partnerships

Shin Nihon Enzyme Co. (exclusive North American distributor)Amano Enzyme Inc. (exclusive North American distributor)

Beyond the preview

Go deeper on BIO-CAT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIO-CAT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call